Nele Vandeputte
Kortrijk, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Acquired von Willebrand syndrome in patients on long-term left ventricular assist device support: Results of a Belgian center.
Journal: Thrombosis research
Published: September 12, 2019
von Willebrand factor in experimental malaria-associated acute respiratory distress syndrome.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 10, 2019
Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Journal: Thrombosis and haemostasis
Published: September 21, 2018
Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device-induced acquired von Willebrand syndrome.
Journal: Research and practice in thrombosis and haemostasis
Published: May 24, 2018
Child-onset thrombotic thrombocytopenic purpura caused by p.R498C and p.G259PfsX133 mutations in ADAMTS13.
Journal: European journal of haematology
Published: May 03, 2018
High and long-term von Willebrand factor expression after Sleeping Beauty transposon-mediated gene therapy in a mouse model of severe von Willebrand disease.
Journal: Journal of thrombosis and haemostasis : JTH
Published: October 27, 2017
Anti-ADAMTS13 Antibodies and a Novel Heterozygous p.R1177Q Mutation in a Case of Pregnancy-Onset Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: September 04, 2017
Long-Term Prevention of Congenital Thrombotic Thrombocytopenic Purpura in ADAMTS13 Knockout Mice by Sleeping Beauty Transposon-Mediated Gene Therapy.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: October 28, 2016
N-acetylcysteine in preclinical mouse and baboon models of thrombotic thrombocytopenic purpura.
Journal: Blood
Published: September 08, 2016
Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor and Plasminogen Activator Inhibitor-1 Reduces Ischemic Brain Damage in Mice.
Journal: Stroke
Published: May 18, 2016
Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura.
Journal: PloS one
Published: March 31, 2016
Last Updated: 09/26/2026